Introduction
ASTEMATE M2, manufactured by Essendon Formulations Private Limited for Astemax Biotech, is a fixed-dose combination tablet containing glimepiride and metformin for type 2 diabetes management.
Essendon Formulations Role
Essendon Formulations Pvt. Ltd., based in Karnal, Haryana, serves as the manufacturing partner specializing in high-quality generic formulations. They produce ASTEMATE M2 under strict GMP standards, ensuring bioavailability and stability for reliable glycemic control in the Indian market.
Product Specifications
Strengths: Commonly available as glimepiride 1/2 mg + metformin 500 mg SR (sustained release).
Benefits: Dual mechanism reduces HbA1c by 1.5-2% more effectively than monotherapy, with lower hypoglycemia risk when taken with meals.
Packaging: Alu-Alu strips of 10×10 or 15 tablets, priced affordably for PCD/franchise distribution.
This collaboration leverages Essendon’s formulation expertise to deliver Astemax’s diabetes portfolio effectively.
